ArticleACS medicinal chemistry letters2021

Structure-Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway Inhibitors.

Zirui Lü et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.